- 1
- 2
Mr DANIEL CASADEVALL LOPEZ
Three factors have led to large experience in licenses and collaborations:
- The consolidated presence of the Juste Group in the Spanish, Central American, and South American markets.
- Our in-house developed products.
- The growing prestige of the company since its beginning.
The Juste Group has a permanent interest in collaborating with development projects and establish license agreements and/or co-promotion for Spain, Portugal, countries from Central and South America, Middle East, and North Africa in the following fields of specialization:
- Radiology/Contrast medium
JUSTESA IMAGEN, S.A.U.
SALES MANAGERMrs Laurence CASSARINO
SANOFI-AVENTI GROUP
Licensing-out Lead - Portfolio Enhancement & Maximisation DptKathrin Casula
Helm AG is a Hamburg- based, privately owned company and represented by own subsidiaries in more
than 30 countries worldwide.
In cooperation with highly acclaimed international partners, Helm offers developments of generic
pharmaceuticals, IP researches, registrations of high quality e-CTD dossiers, launch and life cycle
management.
Our global presence and extensive variety of excellent service functions mean that Helm is your ideal
partner for all stages of the product life cycle from the initial idea generation through to the launch and
supply of the medicinal product.
We offer:
-High quality e-CTD dossiers per current EU-requirements and international registration strategies.
-Tailor made portfolio ideas.
- Excellent project management
- Collaborations for innovative technology platforms.
We are interested in:
- Identifying out-licensing and co-operation opportunities - especially for EU, Nordics, UK, LATAM, MENA
& CIS markets.
- Exploring product & brand acquisition opportunities in the targeted territories.
- Divestment of companies
We are NOT interested in:
- Regulatory Services
- CRO + CMO Services
Helm AG
Senior Licensing ManagerMr Benjamin Chambon
Alira Health is an integrated healthcare consulting firm and fully registered investment bank that provides execution and transaction services, management, regulatory and clinical advisory services and operates in US, EU and Japan with 12 offices.
Our advantage lies in a team of Doctors, Bankers, Scientists and Management Consultants that armed with field specific knowledge make a difference when it comes to find and exploit pathways of growth in the healthcare market.
We work for large medtech, big pharma, biotech companies, digital health, and healthcare providers covering the whole healthcare value chain and we are proudly recognized at a top 8 consulting firms globally in the healthcare market and among the best consulting firms according to Forbes.
Dr Si Chen
Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability.
Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.
Ms Antonella Cimatti
Alfasigma is an Italian pharmaceutical company set up in May 2015 as result of an industrial partnership between two important pharma groups in Italy, Alfa Wassermann and Sigma-Tau. Alfasigma is ranked among the top five players in the pharmaceutical sector in Italy both in terms of Rx and OTC products with a total consolidated turnover of 1,1 billion Euro in 2017 and an headcount of 2.800 employees. Outside Italy, the new company operates directly in 16 countries among which USA, China, Russia, India and most European countries. Alfasigma has a wide range of products on the market in the following therapeutic areas: Gastrointestinal, Vascular, Muscoskeletal/Rheumathology, Cardiovascular, Metabolic, Respiratory. Alfasigma is also focused on research and development, including biotechnological research. Alongside R&D, also Manufacturing is a field where Alfasigma is strongly active with three production plants in Italy out of which the Alanno's plant operating as CMO.